Results 151 to 160 of about 21,507 (222)

Prevalence and Clinical Significance of Occult Hepatitis B Infection in The Gambia, West Africa. [PDF]

J Infect Dis, 2022
Ndow G, Cessay A, Cohen D, Shimakawa Y, Gore ML, Tamba S, Ghosh S, Sanneh B, Baldeh I, Njie R, D'Alessandro U, Mendy M, Thursz M, Chemin I, Lemoine M.   +14 more
europepmc   +1 more source

Prevalence and Molecular Characterization of Chronic and Occult Hepatitis B Virus Infection Among Pregnant Women in St. Petersburg, Russia. [PDF]

Int J Mol Sci
Ostankova YV, Shchemelev AN, Serikova EN, Kusevitskaya MB, Sannikov MV, Gorskaya OA, Basina VV, Shirshova NY, Mashkov IA, Zueva EB, Reingardt DE, Totolian AA.   +11 more
europepmc   +1 more source

Low Risk of Occult Hepatitis B Infection among Vietnamese Blood Donors. [PDF]

Pathogens, 2022
Tung TT, Schmid J, Nghia VX, Cao LC, Linh LTK, Rungsung I, Sy BT, My TN, The NT, Hoan NX, Meyer CG, Wedemeyer H, Kremsner PG, Toan NL, Song LH, Bock CT, Velavan TP.   +16 more
europepmc   +1 more source

Influence of Occult Hepatitis B Infection on Blood Transfusion Safety and Its Countermeasures. [PDF]

Pathogens
Yi M, Dai S, Fang L, Pan B, Fan B, Pan Y, Liu Z.   +6 more
europepmc   +1 more source

Rate of occult hepatitis B virus infection among individuals with tuberculosis in northeastern Iran: A molecular epidemiological study. [PDF]

J Virus Erad, 2023
Ahmadi Ghezeldasht S, Soleimanpour S, Hedayati-Moghaddam MR, Farshchian M, Rezaee SA, Mosavat A.   +5 more
europepmc   +1 more source

The current situation of organ donation from occult hepatitis B infection (OBI) donors: a perspective from Iraq. [PDF]

EClinicalMedicine
Hussein NR, Mahfodh DS.
europepmc   +1 more source

Characterization of occult hepatitis B infection among Iranian liver transplant recipients. [PDF]

J Clin Lab Anal, 2022
Khamseh A, Poortahmasebi V, Soltani S, Nasiritoosi M, Jafarian A, Ghaziasadi A, Norouzi M, Ghorbani S, Eslami N, Jazayeri SM.   +9 more
europepmc   +1 more source

Occult hepatitis B virus infection: risk for a blood supply, but how about individuals' health? [PDF]

EClinicalMedicine
Fu MX, Elsharkawy A, Healy B, Jackson C, Bradshaw D, Watkins E, Ushiro-Lumb I, Griffiths J, Neuberger J, Maguire K, Desai M, McDougall N, Priddee N, Barclay ST, Blackmore S, Simmonds P, Irving WL, Harvala H.   +17 more
europepmc   +1 more source

Clinical Audit of screening Latent TB, Hepatitis-C, and Occult Hepatitis-B in Rheumatoid arthritis' patients starting biologic or targeted synthetic DMARDS. [PDF]

Pak J Med Sci
Qamar HY, Saeed MA, Hameed MR, Aamer M, Arshad U, Lal A.   +5 more
europepmc   +1 more source

Frequent achievement of a drug-free state after orthotopic liver transplantation [PDF]

, 1993
Abu-Elmagd, K, Demetris, AJ, Fung, JJ, Nalesnik, M, Nour, B, Ramos, H, Reyes, J, Starzl, TE, Todo, S, Trucco, M, Tzakis, A, Zeevi, A   +11 more
core